Rapid epigenomic classification of acute leukemia

Tuesday 07 October 2025
08:00 [PDT] 11:00 [EDT] 16:00 [BST]
Alternative time zones
Unlock the potential for faster, more comprehensive leukemia characterization with this webinar from Dana-Farber Cancer Institute expert Salvatore Benfatto.
What will you learn?
- How the leukemia classification approach developed by Dana Farber offers a framework that can be easily implemented anywhere in the world.
- How research with Oxford Nanopore sequencing is unlocking the potential to shorten the diagnosis and classification of acute leukemia to within hours.
- Why rapid and accurate treatment for acute leukemias is crucial to survival rates.
Who this may interest?
- Cancer researchers: basic and translational
- Core lab directors, managers and technicians
- Clinical lab directors, managers and technicians
Speaker
Salvatore Benfatto
Postdoctoral researcher
Dana-Farber Cancer Institute (MA, USA)
Salvatore Benfatto is a postdoctoral researcher at the Dana-Farber Cancer Institute. As a computational biologist, he works at the intersection of artificial intelligence and cancer research. In a multidisciplinary team, he develops machine learning models to foster the next generation of rapid DNA methylation- and AI-powered cancer diagnostics.
In association with
Submit Your Research to the F1000Research Genomics & Genetics Gateway
Advance the fields of genomics and genetics by publishing your research with the F1000Research Genomics & Genetics Gateway. With trusted publishing, open access, and transparent peer review, your work will uphold the highest standards of rigor and integrity while driving innovation in PCR, sequencing, and genetic analysis.
Join a platform that values transparency, openness, and author control. Submit your research today at F1000Research Genomics & Genetics Gateway.